Drugs / BAY1161116
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03119077 | Apr → Sep 2017 | polycystic ovary syndrome | Bayer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY1161116 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03119077 ↗ |
| Route | Oral | “Orally Administered BAY1161116” NCT03119077 ↗ |